Anomalies de la réparation de l’ADN et cancers gynécologiques

2017/10/18 by Aurélie Auguste, Alexandra Leary, Alexandra Léary
Biochemistry, Genetics and Molecular Biology · Medicine · #BRCA gene mutations in cancer #DNA Repair Mechanisms #PARP inhibition in cancer therapy

paper · doi:10.1016/j.bulcan.2017.09.007

openalex publication_date 2017/10/18 · openalex created_date 2017/11/10 · openalex updated_date 2026/07/29

Citations

• Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
• Phase II Study of WEE1 Inhibitor AZD1775 Plus Carboplatin in Patients With TP53-Mutated Ovarian Cancer Refractory or Resistant to First-Line Therapy Within 3 Months